Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 3
Submit an article Journal homepage
104
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The costs of treatment resistant depression: evidence from a survey among Italian patients

Matteo Ruggeria Istituto Superiore Di Sanità, Centro Nazionale per l’HTA, Rome, Italy;b School of Medicine, St.Camillus International University of Medical Sciences, RomeCorrespondence[email protected]
[email protected]
View further author information
,
Carlo Dragoc Università Niccolò Cusano, RomaView further author information
,
Donatella Mandolinid Freelance StatisticianView further author information
,
Pier Francesa Morele Janssen-Cilag SpA, Milano, ItalyView further author information
,
Claudio Mencaccif Department of Neuroscience, ASST Fatebenefratelli Sacco, Milan, ItalyView further author information
&
Fabrizio Staraceg Mental Health Department AUSL Modena, Emilia Romagna, ItalyView further author information
Pages 437-444 | Received 19 Mar 2021, Accepted 08 Jul 2021, Published online: 26 Jul 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Evelyn Walter, Matthäus Traunfellner, Martin Gleitsmann, Michaela Zalesak & Christian Helmenstein. (2023) The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria. Journal of Medical Economics 26:1, pages 1432-1444.
Read now

Articles from other publishers (4)

Carla Rognoni, Camilla Falivena, Francesco Costa & Patrizio Armeni. (2023) Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy. PharmacoEconomics 41:2, pages 209-225.
Crossref
Khosro Keshavarz, Arvin Hedayati, Mojtaba Rezaei, Zahra Goudarzi, Ebrahim Moghimi, Mehdi Rezaee & Farhad Lotfi. (2022) Economic burden of major depressive disorder: a case study in Southern Iran. BMC Psychiatry 22:1.
Crossref
Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, Federica Fiaschè, Clarissa Zocchi, Alessio Padovano, Ottavia De Luca, Gloria Angeletti, Roberto Brugnoli, Paolo Girardi, Robert Preissner, Marina Borro, Giovanna Gentile, Maurizio Pompili & Maurizio Simmaco. (2022) Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study. Journal of Personalized Medicine 12:2, pages 316.
Crossref
Yuan Zhang, Mei Wang, Xiaotong Zhang, Zhenyi Jiang, Yuanxiang Zhang, Xiangjun Fu, Yanna Li, Danping Cao, Jun Han & Jiucui Tong. (2022) Helicid Improves Lipopolysaccharide-Induced Apoptosis of C6 Cells by Regulating SH2D5 DNA Methylation via the CytC/Caspase9/Caspase3 Signaling Pathway. Contrast Media & Molecular Imaging 2022, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.